STOCK TITAN

BrightSpring Health Services, Inc. - BTSG STOCK NEWS

Welcome to our dedicated page for BrightSpring Health Services news (Ticker: BTSG), a resource for investors and traders seeking the latest updates and insights on BrightSpring Health Services stock.

BrightSpring Health Services, Inc. (NASDAQ: BTSG) is a prominent provider of home and community-based healthcare services, catering to complex patient populations. The company's comprehensive platform delivers a range of clinical and pharmacy services across Medicare, Medicaid, and commercially insured groups.

Core Business: BrightSpring operates through several key segments, including Pharmacy Solutions and Provider Services. The Pharmacy Solutions segment, generating the majority of the company's revenue, focuses on delivering comprehensive pharmaceutical care and specialty drugs, while the Provider Services segment offers diverse healthcare solutions, including home health care, rehabilitation, and behavioral health services.

Recent Achievements: BrightSpring has recently expanded its footprint through strategic acquisitions, including a home health operation in Maryland, a behavioral therapy company in Michigan, and a long-term care pharmacy in Montana. These acquisitions bolster BrightSpring’s market penetration and enhance its capacity to deliver quality care directly to patient residences.

Since 2017, over 200 BrightSpring employees have received national recognition for exemplary service in areas such as human resources, marketing, and quality care. Seven employees were honored with the prestigious 2024 DSP of the Year Award from ANCOR, highlighting their dedication to high-need populations.

Innovative Projects: BrightSpring's home health and hospice service line, Adoration Home Health & Hospice, recently won accolades for its “Same Day, Next Day” campaign, which emphasizes timely home health care for post-hospitalization patients. This initiative has led to improved patient outcomes, increased referrals, and higher staff morale.

Financial Condition: BrightSpring remains robust, supported by strong revenue streams primarily from its Pharmacy Solutions segment. The company maintains a strategic focus on expanding its services and geographical reach through partnerships and acquisitions.

Partnerships and Collaborations: Notably, Onco360®, a subsidiary of BrightSpring, has partnered with Alexion Pharmaceuticals and Day One Biopharmaceuticals to deliver cutting-edge oncology medications. These collaborations underscore BrightSpring’s commitment to providing advanced treatment options for patients with complex and rare diseases.

Community Impact: BrightSpring also focuses on fostering a supportive work environment, recently awarding stock grants to thousands of employees as a token of appreciation for their dedication. This initiative aims to further align employee interests with the company's long-term goals.

Overall, BrightSpring Health Services continues to innovate and expand its comprehensive care model, positively impacting the lives of over 400,000 customers, clients, and patients daily across the United States.

Rhea-AI Summary

BrightSpring Health Services (NASDAQ: BTSG) has announced it will release its second quarter 2024 financial results on August 2, 2024. The report will be made available before the company's earnings conference call scheduled for 8:30 a.m. ET on the same day. Investors and interested parties can register to participate in the call and access a live and archived webcast on the company's investor relations website. Presentation materials will be posted on the site prior to the call.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.89%
Tags
-
Rhea-AI Summary

BrightSpring Health Services (NASDAQ: BTSG) has announced a definitive agreement to acquire the assets of Haven Hospice in Florida for $60 million. Haven holds a Certificate of Need for comprehensive hospice care in 18 counties. This acquisition allows BrightSpring to expand its hospice services into Florida, an important yet challenging market to enter. The deal includes $15 million in cash, $30 million in Company equity, and $15 million in a seller note payable in four years. The acquisition is set to close in Q3 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.39%
Tags
-
Rhea-AI Summary

BrightSpring Health Services (NASDAQ: BTSG), a leading provider of home and community-based health services, has awarded scholarships to five Louisville students. The 2024 Brighter Futures Scholarship was given to Layah Hodges, while the Hospice Nursing Scholarship was awarded to Morgan Harper, Chasta May, Samyah Edwards, and Onileola Ilesanmi. The Brighter Futures Scholarship offers $10,000 annually, renewable for up to four years, totaling $40,000. The Hospice Nursing Scholarship provides $5,000 per year for up to two years, totaling $10,000. These scholarships are part of BrightSpring's commitment to support under-reached students pursuing healthcare careers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.62%
Tags
none
Rhea-AI Summary

BrightSpring Health Services (NASDAQ: BTSG) has completed its $100 million equity grant to approximately 20,000 of its full-time and tenured employees. This initiative, announced during the company's IPO on January 26, was designed to recognize and reward the hard work of its staff. Employees eligible for the grant are those who work 32+ hours per week with a one-year lookback and those with at least one year of continuous service by March 31, 2024. According to President and CEO Jon Rousseau, this grant aims to foster an ownership culture and incentivize more healthcare professionals to join BrightSpring.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.4%
Tags
none
-
Rhea-AI Summary

BrightSpring Health Services (NASDAQ: BTSG) announced its participation in three significant investor conferences. The company will engage in fireside chats at:

- The 2024 Leerink Partners Healthcare Crossroads Conference on May 30th at 8:40 AM CT.

- The Jefferies Global Healthcare Conference on June 6th at 9 AM ET.

- The Goldman Sachs 45th Annual Global Healthcare Conference on June 10th at 11:20 AM ET.

Live and archived webcasts of these events will be accessible through the BrightSpring investor relations website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.44%
Tags
conferences
-
Rhea-AI Summary

BrightSpring Health Services (NASDAQ: BTSG) announced several recent acquisitions aimed at enhancing its geographic reach and expanding its service lines. Key acquisitions include a home-based primary care group in Arkansas, an institutional special needs health plan in Kentucky and Tennessee, and a home and community pharmacy in Texas. These acquisitions, effective from May 1 and May 3, 2024, aim to strengthen BrightSpring's medical and pharmacy services for complex populations in various settings from home health to long-term care. CEO Jon Rousseau highlighted the company's strategy to integrate service lines and deliver high-quality care directly to where people reside.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.96%
Tags
Rhea-AI Summary

BrightSpring Health Services (NASDAQ: BTSG) announced that its subsidiary, Onco360®, has been selected as the national pharmacy partner for OJEMDA™, a newly FDA-approved treatment for pediatric low-grade glioma (LGG) with BRAF mutations. This partnership with Day One Biopharmaceuticals aims to provide this cutting-edge, once-weekly oral medication to children aged six months and older who have relapsed or refractory LGG. The approval is based on the FIREFLY-1 clinical trial, and ongoing confirmatory trials are required for continued approval. Onco360® offers specialized oncology medications and support services, including financial assistance, clinical counseling, and insurance verification.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.17%
Tags
none
-
Rhea-AI Summary

BrightSpring Health Services, Inc. reported strong financial results for Q1 2024, with net revenue of $2,577 million, a 27.0% increase from Q1 2023. The company's Adjusted EBITDA was $131 million, up 13.2% year-over-year. BrightSpring appointed Timothy Wicks to the Board of Directors and increased its 2024 revenue and Adjusted EBITDA guidance. The company is optimistic about its outlook for the year, citing growth in both Pharmacy and Provider segments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.75%
Tags
-
Rhea-AI Summary

BrightSpring Health Services, Inc. appointed Timothy A. Wicks as a new member of the Board of Directors, bringing over 20 years of executive leadership experience in the healthcare industry. Mr. Wicks has held various leadership positions at UnitedHealth Group, including as Executive Vice President of Optum Inc. His appointment aims to drive growth, innovation, and leadership at BrightSpring.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.12%
Tags
management
Rhea-AI Summary
BrightSpring Health Services' Onco360® selected as national pharmacy partner by Alexion Pharmaceuticals for innovative drug Voydeya® to treat patients with PNH experiencing EVH.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
none

FAQ

What is the current stock price of BrightSpring Health Services (BTSG)?

The current stock price of BrightSpring Health Services (BTSG) is $19.575 as of November 8, 2024.

What is the market cap of BrightSpring Health Services (BTSG)?

The market cap of BrightSpring Health Services (BTSG) is approximately 3.3B.

What services does BrightSpring Health Services provide?

BrightSpring offers home and community-based healthcare services, including pharmacy solutions, primary care, rehabilitation, and behavioral health services.

What is the main source of revenue for BrightSpring?

The main source of revenue for BrightSpring comes from its Pharmacy Solutions segment.

What recent acquisitions has BrightSpring made?

BrightSpring recently acquired a home health operation in Maryland, a behavioral therapy company in Michigan, and a long-term care pharmacy in Montana.

How many employees have been recognized for their service at BrightSpring?

Since 2017, over 200 employees have been recognized for their service in various categories such as human resources, marketing, and quality care.

What is Adoration Home Health & Hospice known for?

Adoration Home Health & Hospice is known for its award-winning 'Same Day, Next Day' campaign, which emphasizes timely home health care for post-hospitalization patients.

Who are BrightSpring's key partners in oncology medication?

BrightSpring's subsidiary Onco360® has partnered with Alexion Pharmaceuticals and Day One Biopharmaceuticals to deliver advanced oncology medications.

How many people does BrightSpring serve daily?

BrightSpring serves over 400,000 customers, clients, and patients daily across the United States.

What recent awards have BrightSpring employees received?

Seven BrightSpring employees received the 2024 DSP of the Year Award from ANCOR for their dedication to high-need populations.

How does BrightSpring support its employees?

BrightSpring has awarded stock grants to thousands of employees to appreciate their dedication and align their interests with the company's long-term goals.

What types of health conditions does BrightSpring focus on?

BrightSpring focuses on providing care for complex and chronic conditions, including specialized pharmacy solutions and home health care services.

BrightSpring Health Services, Inc.

Nasdaq:BTSG

BTSG Rankings

BTSG Stock Data

3.31B
174.13M
13.96%
100.25%
4.07%
Health Information Services
Services-home Health Care Services
Link
United States of America
LOUISVILLE